QA: Evolus Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001570562_2023_Evolus_Inc.pdf

Logs

Graph

Absolute values for 0001570562, Evolus Inc.

  xvar xval
0 AssetsCurrent 100,802,000
1 IntangibleAssetsNetIncludingGoodwill 69,805,000
2 PropertyPlantAndEquipmentNet 2,616,000
3 remainder_Assets 4,760,000
4 LiabilitiesCurrent 46,509,000
5 LiabilitiesNoncurrent 1,224,000
6 remainder_Liabilities 111,751,000
7 CostOfGoodsAndServicesSold 55,887,000
8 SellingGeneralAndAdministrativeExpense 141,840,000
9 ResearchAndDevelopmentExpense 4,742,000
10 remainder_Expenses 20,669,000
11 remainder_Revenues 148,616,000
12 remainder_NetIncome 110,000
13 remainder_ComprehensiveNetIncome -337,000
  yvar yval
0 Assets 177,983,000
1 Liabilities 159,484,000
2 Expenses 223,138,000
3 Revenues 148,616,000
4 StockholdersEquity 18,499,000
5 NetIncome -74,412,000
6 ComprehensiveNetIncome -74,580,500
7 BaseVar 354,834,000
8 EconomicCapitalRatio -0.253

Edgar->Model Mapping

Feature Distribution

Change over Time